Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection

Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection

The impact of the coronavirus disease 2019 (COVID‐19) pandemic among patients with chronic liver disease is unknown. Given the high prevalence of nonalcoholic fatty liver disease (NAFLD), we determined the predictors of mortality and hospital resource use among patients with NAFLD admitted with COVI...

Full description

Bibliographic Details
Main Authors:	Zobair M. Younossi, Maria Stepanova, Brian Lam, Rebecca Cable, Sean Felix, Thomas Jeffers, Elena Younossi, Huong Pham, Manirath Srishord, Patrick Austin, Michael Estep, Kathy Terra, Carey Escheik, Leyla deAvila, Pegah Golabi, Andrej Kolacevski, Andrei Racila, Linda Henry, Lynn Gerber
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2022-11-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1802

Similar Items

The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19
by: Maria Stepanova, et al.
Published: (2022-08-01)

Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
by: Pegah Golabi, et al.
Published: (2020-08-01)

Predictors of chronic liver disease in individuals with human immunodeficiency virus infection
by: Nila Rafiq, et al.
Published: (2014-01-01)

Association of Parity in Patients with Chronic Liver Disease
by: Pegah Golabi, et al.
Published: (2018-11-01)

Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease
by: Ali A. Weinstein, et al.
Published: (2023-12-01)

Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC
by: Zobair M. Younossi, et al.
Published: (2023-02-01)

Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality
by: Omer Shahab, et al.
Published: (2018-10-01)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
by: Pegah Golabi, et al.
Published: (2022-01-01)

Nonalcoholic steatohepatitis: global impact and clinical consequences
by: Khaled Kabarra, et al.
Published: (2021-10-01)

Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease
by: Pegah Golabi, et al.
Published: (2020-12-01)

Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example.
by: Sandra Page, et al.
Published: (2013-01-01)

Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis
by: Mehmet Sayiner, et al.
Published: (2018-11-01)

The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007‐2017
by: James M. Paik, et al.
Published: (2021-05-01)

Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
by: James M. Paik, et al.
Published: (2019-11-01)

Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data
by: James M. Paik, et al.
Published: (2022-01-01)

Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system.
by: Brian Lam, et al.
Published: (2022-01-01)

Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease
by: Pegah Golabi, et al.
Published: (2019-08-01)

The Prevalence of Parkinson Disease Among Patients With Hepatitis C Infection
by: Pegah Golabi, et al.
Published: (2017-05-01)

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
by: Pegah Golabi, et al.
Published: (2019-04-01)

Sarcopenia, healthy living, and mortality in patients with chronic liver diseases
by: Catherine Van Dongen, et al.
Published: (2022-11-01)

Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States
by: James M. Paik, et al.
Published: (2020-06-01)

Poor Awareness of Liver Disease Among Adults With NAFLD in the United States
by: Saleh A. Alqahtani, et al.
Published: (2021-11-01)

Non-alcoholic Steatohepatitis: Global Impact and Clinical Consequences
by: Zobair Younossi, et al.
Published: (2022-03-01)

Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD
by: Joana Vieira Barbosa, et al.
Published: (2022-04-01)

Review: Treatment options for nonalcoholic fatty liver disease
by: Brian Lam, et al.
Published: (2010-03-01)

Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute Infection
by: Price JK, et al.
Published: (2023-04-01)

The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment
by: Brian P. Lam, et al.
Published: (2015-09-01)

A multistakeholder approach to innovations in NAFLD care
by: Jörn M. Schattenberg, et al.
Published: (2023-01-01)

Non-Invasive markers for hepatic fibrosis
by: Lal Priyanka, et al.
Published: (2011-08-01)

The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry
by: Zobair M. Younossi, et al.
Published: (2022-10-01)

Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women
by: Price JK, et al.
Published: (2023-09-01)

Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)
by: James M. Paik, et al.
Published: (2023-07-01)

Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis
by: Michael Estep, et al.
Published: (2019-02-01)

Corrigendum to ‘Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B’ [JHEP Reports 3 (2021)]
by: Maria Buti, et al.
Published: (2022-09-01)

Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
by: Maria Buti, et al.
Published: (2021-06-01)

Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis
by: Ryuki Hashida, et al.
Published: (2021-08-01)

Hospice care utilisation among elderly patients who died with hepatocellular carcinoma in the United States
by: Victor de Avila, et al.
Published: (2021-04-01)

The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes
by: Zobair Younossi, et al.
Published: (2022-09-01)

Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease
by: Zobair Younossi, et al.
Published: (2017-11-01)

Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007‐2016
by: Tamoore Arshad, et al.
Published: (2021-10-01)